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| INTRODUCTION
von Willebrand factor (VWF) is a multimeric glycoprotein that mediates platelet adhesion and aggregation at the site of blood vessel injury under. High molecular weight VWF multimers (HMWM) exhibit greater platelet-binding activities and have been associated with an increased risk for thrombosis. Shear stress applied to VWF causes a conformational change in VWF structure from its globular to an elongated form, exposing the platelet GPIb binding site in the VWF A1 domain 1 and resulting in platelet tethering to VWF. GPIb binding activates the GPIIbIIIa receptor complex that mediates firm attachment of platelets through interactions with the Arg-Gly-Asp sequence in the VWF C4 domain, resulting in platelet thrombus formation.
2,3
von Willebrand factor activity is regulated by the protease A disintegrin-like and metalloprotease with thrombospondin type I repeats-13 (ADAMTS13), 4 that cleaves HMWM to reduce the hemostatic efficacy of VWF. Exposure of VWF to shear stress or tensile stretching forces applied by captured platelets causes VWF to undergo a conformational change from a globular to an elongated form, thereby exposing cryptic ADAMTS13-binding exosites on VWF and facilitating ADAMTS13-mediated proteolysis. 5, 6 Using an in vitro flow chamber model, we and others have previously demonstrated that ADAMTS13
can regulate platelet thrombus formation in a VWF-dependent manner under conditions of pathological shear. [6] [7] [8] However, the influence of platelet-applied tensile forces on ADAMTS13 activity within the platelet thrombus is unknown. Additionally, although we observed products of VWF cleavage by ADAMTS13 within the platelet thrombus, the localization of ADAMTS13 within the platelet thrombus has not been directly observed. In these studies, we generated a recombinant murine ADAMTS13 protein fused to the mCherry fluorophore to directly visualize the localization of ADAMTS13 within the platelet thrombus. We then characterized the contribution of tensile forces mediated by platelet-VWF tethering involving GPIb and GPIIbIIIa receptors to ADAMTS13 localization and activity within a platelet thrombus using a flow chamber model.
| METHODS

| Plasmid construction and recombinant protein production
The mCherry cDNA (Clontech, Mountainview, CA) was cloned into the full-length murine ADAMTS13 cDNA pcDNA3.1 following a 12-amino acid linker (GGGSGGGGSGGG Two U/mL of mADAMTS13-mCherry diluted in PBS or mock transfected media diluted in PBS were added to the whole blood and were perfused into the prepared flow chamber at the indicated shear rates for 9 minutes controlled by a syringe pump (New Era Pump Systems Inc., Farmingdale, NY, USA; NE-1600). Platelet accumulation and ADAMTS13-cherry association was imaged using a Quorum WaveFX-X1 spinning disk confocal system (Quorum Technologies, Inc., Guelph, ON, Canada) with a Hamamatsu Orca high resolution camera (Hamamatsu, Japan). In some experiments, whole blood was obtained from VWF/ADAMTS13 DKO mice and 2 U/mL recombinant mADAMTS13 and 2 U/mL mVWF (WT, V1316M, RGG) were added and used for the experiments.
For the direct visualization of ADAMTS13-cherry association with accumulating platelets, rabbit anti-mCherry antibody (BioVision, Milpitas, CA, USA) and an anti-rabbit IgG-Alexa568 (Molecular Probes, Eugene, OR, USA) were incubated for 30 minutes and mixed with mADAMTS13-mCherry for 15 minutes and added to anticoagulated blood prior to the experiments. All mouse experiments were reviewed and approved by the Queen's University Animal Care Committee.
| Immunostaining of thrombi post-flow chamber experiments
Thrombi were fixed with Cytoperm/Cytofix (Becton Dickinson, Franklin
Lakes, NJ, USA) and immunofluorescent staining was performed to further analyze the distribution of platelets, VWF and ADAMTS13. The
Essentials
• The regulation of platelet thrombus growth by ADAMTS13 is not well characterized.
• Platelet thrombus formation in a flow chamber was assessed with mCherry-tagged ADAMTS13.
• ADAMTS13 colocalized with VWF and platelets to the middle and top portions of the thrombus.
• Platelet tethering to VWF by GPIB enhanced ADAMTS13 localization to the thrombus.
thrombus was permeabilized with PBS/1% Triton X-100 for 10 minutes at room temperature, blocked with serum free protein block (Dako) for 20 minutes and incubated with a rabbit anti-mCherry antibody overnight at 4°C, followed by goat anti-rabbit IgG-Alexa568 for 8 hours at with thrombi formed from blood collected from VWF/ADAMTS13 DKO mice were used to confirm staining experiments.
| Imaging analysis
Image analysis was performed on fixed and permeabilized immu- 
| Data presentation and statistics
All data and statistical analysis was performed using Graphpad Prism 6.0 (Graphpad software). The results are shown as means ± SEM.
Statistical significance was assessed using Student's t tests or two-way Analysis of variance.
| RESULTS AND DISCUSSION
The activity of ADAMTS13-mCherry was first measured by a functional ELISA using the VWF73mer substrate. This proved to be comparable to wild type ADAMTS13 (data not shown) and the concentration was normalized to normal pooled plasma (defined as 1 U/mL). 12 The ability of ADAMTS13-mCherry to cleave urea-treated murine rVWF was confirmed by multimeric analysis ( Figure 1A ). We next evaluated the ability of ADAMTS13-mCherry to cleave VWF in a flow chamber model. In this model, the rate of shear within the flow chamber is initially applied at a controlled rate by the syringe pump. As the platelet thrombus grows in size, it generates a partial occlusion within the chamber that increases the localized shear stress overlying the platelet thrombus, that in turn promotes the transformation of VWF from its globular to its elongated form, 14 thereby exposing the cryptic ADAMTS13 cleavage site on thrombus-anchored VWF. The ability of ADAMTS13-mCherry to reduce the platelet thrombus surface area coverage and thrombus volume in a shear-dependent manner was confirmed after a 9-minute perfusion ( Figure 1B,C) . We also directly visualized the association of ADAMTS13-mCherry with platelet-VWF structures using a fluorescently tagged anti-mCherry antibody under conditions of very high shear (7500 s −1 ) ( Figure 1D and Figure S1 ). The localization of ADAMTS13 was partially associated with platelets, and resembled VWF string-like structures.
ADAMTS13 staining was not detected at 2500 s −1 and 500 s to an elongated conformation. 5 We observed a strong association between ADAMTS13, VWF, and platelets suggesting involvement of platelet GPIb and GPIIbIIIa receptors in facilitating these interactions. We then modified the platelet-binding ability of our recombinant murine VWF using the gain-of-function GPIb binding mutation VWD patients demonstrate loss of HMWMs and a bleeding phenotype related in part to increased ADAMTS13-mediated VWF proteolysis secondary to enhanced GPIb tensile forces applied to the VWF molecule. 15, 16 In contrast, the VWF RGG variant, with loss of GPIIbIIIa binding, had minimal influence on ADAMTS13 localization ( Figure 3C ).
There are several potential reasons for this observation. 
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